NAUT (STOCKS)
Nautilus Biotechnolgy, Inc. Common Stock
$2.190000
+0.060000 (+2.82%)
Prev close: $2.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sujal M. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $276.61M
- Employees
- 124
- P/E (TTM)
- -4.40
- P/B (TTM)
- 1.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.11 | $-0.15 | +0.0430 | +28.10% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.16 | +0.0381 | +24.10% |
|
Mar 2025 (Q1)
|
$-0.13 | $-0.15 | +0.0195 | +13.04% |
|
Dec 2024 (Q4)
|
$-0.14 | $-0.17 | +0.0252 | +15.25% |
Financial Statements
| Assets | $200.92M |
| Current Assets | $134.33M |
| Cash | $131.40M |
| Other Current Assets | $2.93M |
| Noncurrent Assets | $66.59M |
| Fixed Assets | $3.62M |
| Other Non-current Assets | $62.97M |
| Liabilities | $31.78M |
| Current Liabilities | $8.98M |
| Accounts Payable | $893.00K |
| Wages | $3.00M |
| Other Current Liabilities | $5.09M |
| Noncurrent Liabilities | $22.79M |
| Equity | $169.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $169.14M |
| Liabilities And Equity | $200.92M |